Medeon Biodesign, Inc. (6499.TWO)

TWD 39.6

(-1.0%)

EBITDA Summary of Medeon Biodesign, Inc.

  • Medeon Biodesign, Inc.'s latest annual EBITDA in 2023 was -1.14 Billion TWD , down -208.54% from previous year.
  • Medeon Biodesign, Inc.'s latest quarterly EBITDA in 2024 Q2 was -189.14 Million TWD , down -0.27% from previous quarter.
  • Medeon Biodesign, Inc. reported an annual EBITDA of -370.1 Million TWD in 2022, up 18.46% from previous year.
  • Medeon Biodesign, Inc. reported an annual EBITDA of -453.86 Million TWD in 2021, down -76.7% from previous year.
  • Medeon Biodesign, Inc. reported a quarterly EBITDA of -189.27 Million TWD for 2024 Q1, up 4.55% from previous quarter.
  • Medeon Biodesign, Inc. reported a quarterly EBITDA of -165.85 Million TWD for 2023 Q1, up 6.71% from previous quarter.

Annual EBITDA Chart of Medeon Biodesign, Inc. (2023 - 2019)

Historical Annual EBITDA of Medeon Biodesign, Inc. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 -1.14 Billion TWD -208.54%
2022 -370.1 Million TWD 18.46%
2021 -453.86 Million TWD -76.7%
2020 -256.45 Million TWD -49.78%
2019 -172.08 Million TWD 0.0%

Peer EBITDA Comparison of Medeon Biodesign, Inc.

Name EBITDA EBITDA Difference
St.Shine Optical Co.,Ltd. 1.01 Billion TWD 212.945%
Bioteque Corporation 736.13 Million TWD 255.123%
Chi Sheng Pharma & Biotech Co., Ltd 117.55 Million TWD 1071.416%
Sunder Biomedical Tech. Co., Ltd. 76.61 Million TWD 1590.503%
BenQ Medical Technology Corporation 532.15 Million TWD 314.585%
Pacific Hospital Supply Co., Ltd 673.8 Million TWD 269.474%
Unicon Optical Co., Ltd. 377.24 Million TWD 402.696%
Formosa Optical Technology Co.,Ltd. 1.04 Billion TWD 209.226%
Concord Medical Co., Ltd. 137.47 Million TWD 930.644%
Crystalvue Medical Corporation 149.73 Million TWD 862.647%
Perfect Medical Industry Co., Ltd. 115.48 Million TWD 1088.846%
ICARES Medicus, Inc. 165.54 Million TWD 789.81%
Lagis Enterprise Co., Ltd. 112.36 Million TWD 1116.268%
Amed Co., Ltd. 157.32 Million TWD 825.83%